Elevated B‐cell and CD4+ T‐cell frequencies were a disease‐specific feature of MS, while reduced T‐bet+ and CXCR3+ B‐cell levels were associated with progressive disease. The gene discussed is CD4; the disease is myeloid sarcoma.